A recent survey conducted jointly by Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, and People Management Association of the Philippines (PMAP) on 250 HR practitioners found that two-thirds (65%) have already arranged, or are in the process of arranging, the purchase of vaccines on their employees’ behalf.
Two-thirds of companies have already arranged, or are in the process of arranging, the purchase of vaccines on their employees’ behalf.
MANILA- AMID the news on the development and availability of COVID-19 vaccines, an increasing number of organizations in the Philippines have sought information on how companies plan to manage vaccinations for their workforce.
A recent survey conducted jointly by Willis Towers Watson (NASDAQ: WLTW), a leading global advisory, broking and solutions company, and People Management Association of the Philippines (PMAP) on 250 HR practitioners found that two-thirds (65%) have already arranged, or are in the process of arranging, the purchase of vaccines on their employees’ behalf.
Among the employers who had not started the process, 58% are considering doing so and 42% of companies have no plans of purchasing the vaccines.
In addition, 60% of the respondents, have also indicated that they are working on the procurement of vaccines for the dependents of their employees.
Among those who had not started the process yet, 52% are considering to procure the vaccines for their dependents, and almost half (48%) are not.
When procuring or facilitating the purchase of the vaccine for employees’ dependents, over half of the respondents have indicated that these would include spouse, parents of single employees and children, all of whom are residing with their employees.
Over 40% plan to include the parents of married employees, siblings of single employees, and anyone residing within the household of their employees.
When considering the procurement of vaccines for their employees, 68% of companies said they would fully pay for these vaccines. One in ten (11%) indicated that they would subsidize the cost, but not shoulder a 100% payment of it.
A small proportion of 7% said that the company’s financial support would be limited to a segment of their employees’ population.
Amongst these, half said they would pay for the vaccines for permanent employees only. As for dependents and/or household members, the vast majority (71%) of companies would pass on the full cost to their employees.
For companies that are considering procurement, 70% of employers have indicated that they are running a survey to determine the number of employees who are interested in being vaccinated.
Among those not conducting the survey, 30% have indicated that they have just not gotten around to doing so, 16% are waiting to find out what their peers are doing and 15% prefer to run the survey once the order of their vaccine is confirmed.
When it comes to vaccine administration, 37% of companies are considering a third-party administrator other than their HMO or onsite clinic, 29% have not thought about administration yet, 19% will work with their HMOs for vaccine administration and 15% with their onsite clinic provider.